A Longitudinal Study in Parkinson's Disease (PD) Patients
Trial
N/A
Unknown
Nov. 20, 2012
Investigation of Road-crossing Safety Before and After Training Between Parkinson Disease Pedestrians and Older Pedestrians
Trial
N/A
Unknown
Nov. 15, 2012
Psychosocial Treatment of Depression in Parkinson's Disease
Trial
N/A
Unknown
Nov. 15, 2012
Transcranial Magnetic Stimulation to Treat Parkinson's Disease
Trial
Phase 1
Completed
Nov. 14, 2012
Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial
Trial
N/A
Unknown
Nov. 7, 2012
Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol
Trial
N/A
Unknown
Nov. 7, 2012
Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Trial
N/A
Withdrawn
Nov. 5, 2012
NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
Trial
Phase 2
Completed
Nov. 1, 2012
Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease
Trial
N/A
Completed
Oct. 30, 2012
Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor
Trial
N/A
Unknown
Oct. 28, 2012
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia
Trial
Phase 2
Completed
Oct. 25, 2012
The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease.
Trial
Phase 4
Terminated
Oct. 21, 2012
Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial
Trial
N/A
Unknown
Oct. 17, 2012
Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Trial
Phase 2
Completed
Oct. 10, 2012
Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
Trial
Phase 4
Terminated
Oct. 3, 2012
The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease
Trial
N/A
Terminated
Oct. 3, 2012
Exercise for People With Parkinson's Disease
Trial
Phase 2
Completed
Oct. 1, 2012
Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease
Trial
Phase 2
Completed
Sept. 25, 2012
A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE
Trial
Phase 1
Unknown
Sept. 12, 2012
Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease
Trial
Phase 2
Completed
Sept. 10, 2012